You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Prolonged Medical Cannabis Treatment is Associated With Quality of Life Improvement and Reduction of Analgesic Medication Consumption in Chronic Pain Patients
|
---|---|
Published in |
Frontiers in Pharmacology, May 2021
|
DOI | 10.3389/fphar.2021.613805 |
Pubmed ID | |
Authors |
Joshua Aviram, Gil M. Lewitus, Yelena Vysotski, Ben Yellin, Paula Berman, Anna Shapira, David Meiri |
X Demographics
The data shown below were collected from the profiles of 63 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 16 | 25% |
Canada | 4 | 6% |
Spain | 3 | 5% |
United Kingdom | 2 | 3% |
India | 1 | 2% |
Costa Rica | 1 | 2% |
Norway | 1 | 2% |
San Marino | 1 | 2% |
Denmark | 1 | 2% |
Other | 5 | 8% |
Unknown | 28 | 44% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 55 | 87% |
Practitioners (doctors, other healthcare professionals) | 5 | 8% |
Scientists | 3 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 51 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 51 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 7 | 14% |
Researcher | 4 | 8% |
Student > Postgraduate | 4 | 8% |
Student > Ph. D. Student | 4 | 8% |
Professor | 3 | 6% |
Other | 8 | 16% |
Unknown | 21 | 41% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 7 | 14% |
Psychology | 3 | 6% |
Nursing and Health Professions | 2 | 4% |
Agricultural and Biological Sciences | 2 | 4% |
Neuroscience | 2 | 4% |
Other | 10 | 20% |
Unknown | 25 | 49% |
Attention Score in Context
This research output has an Altmetric Attention Score of 57. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 May 2023.
All research outputs
#765,316
of 25,934,224 outputs
Outputs from Frontiers in Pharmacology
#283
of 20,053 outputs
Outputs of similar age
#20,668
of 460,765 outputs
Outputs of similar age from Frontiers in Pharmacology
#20
of 986 outputs
Altmetric has tracked 25,934,224 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 20,053 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 460,765 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 986 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.